Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

Arysta agreement

8 Feb 2010 07:00

RNS Number : 7903G
Plant Impact PLC
08 February 2010
 



 

8 February 2010

 

Plant Impact plc

 

("Plant Impact" or the "Company")

 

 

Plant Impact and Arysta LifeScience Sign Evaluation, Development and Distribution Agreement for Crop Nutrient Products

 

 

Plant Impact plc (AIM:PIM), a global developer of technologies that improve crop productivity, is pleased to announce that on 5 February 2010 it entered into an exclusive evaluation, development and distribution agreement (the "agreement") with Arysta LifeScience Corporation covering the Company's InCa, Balance and Cocoa Stress Tolerance products (the "Crop Nutrient Products").

 

This is a significant milestone for Plant Impact as the agreement will:

·; extend territorial coverage of the Crop Nutrient Products from 24 countries to 52 countries.

·; increase field trial development of the Crop Nutrient Products. Arysta LifeScience is planning approximately 350 field trials over the next 12 to 18 months which means that, including the Company's currently planned field trial programme, this will result in more than 500 field trials being conducted.

·; increase the commercial potential of the Crop Nutrient Products.

 

The agreement covers countries in North America (excluding InCa), Central and Latin America, Europe, Africa and the Far East. Initial crop targets are in high value horticulture with potential extension into some arable crops.

 

Pursuant to the agreement, Arysta LifeScience will have exclusivity to evaluate the Crop Nutrient Products until 31 March 2011. The evaluation of the Crop Nutrient Products represents the field trial development stage referred to above and will be carried out to research standard. Once this is complete Arysta LifeScience will ensure products are registered locally, and will market and distribute these products on an exclusive basis. Detailed development and distribution agreements will be signed country by country as they come on stream.

 

"Plant nutrients are an important and growing component of our product portfolio", said Wayne Hewett, president and CEO of Arysta LifeScience. "The combination of Plant Impact's innovation platform and our global market development and distribution capabilities make an exciting partnership. We are delighted to further strengthen our relationship with Plant Impact".

 

Pete Blezard, CEO of Plant Impact commented, "This is a tremendous achievement for all stakeholders involved. Agriculture is challenged to feed the world during a time when the population is increasing and natural resources are decreasing. We firmly believe that new science and technologies that are sustainable, environmentally safe, which increase crop marketable yield and yet are able to decrease wastage and conserve natural resources are the way forward. Plant Impact has such science and technologies. With this agreement our company has significantly expanded its route to market and continues to prove efficacy and commercial viability."

 

 

For further information, please contact:

Plant Impact Plc

Peter Blezard, Chief Executive Officer

+44 (0) 1772 645 164

Nominated Adviser and Joint Broker

Allenby Capital

Nick Naylor / Jamie Boyd

 

+44 (0) 20 3328 5661

Joint Broker

Hybridan LLP

Stephen Austin / Claire Noyce

+44 (0) 207 947 4004

 

Financial PR/IR

Conduit PR

Charlie Geller

+44 (0) 20 7429 6604

 

 

Notes to Editors

 

About Arysta LifeScience Corporation

Headquartered in Tokyo, Japan, Arysta LifeScience is the world's largest privately held crop protection and life science company with 2008 revenues of US$1.3 billion. An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide. More than three-quarters of the Arysta LifeScience organisation is directly involved in bringing products to market, from more than 1,200 sales and marketing representatives working with growers, to development and registration teams, to supply chain specialists.

 

More information on Arysta LifeScience is available at: www.arystalifescience.com.

 

About Plant Impact plc

 

Plant Impact addresses the increasing global demand for effective, sustainable and ecologically-sound products to combat environmental plant stress and improve crop productivity. Common environmental plant stresses include drought, salinity, nutrient deficiencies, pests and disease. Plant Impact's advances produce practical results that reduce inputs and benefit the whole of the agricultural value chain, providing solutions for growers, food manufacturers and consumers.

 

A broad product portfolio has been developed using these innovative and proprietary technologies, the most advanced of which are already being marketed and sold through established agricultural distribution networks. Products for the home and garden market are also distributed direct to consumers through reputable high street stores.

 

About InCa

 

InCa is a product derived from Plant Impact's CaT technology. This technology is a calcium absorption aid. In trials it has been found to deliver calcium to the plant up to 50 times more effectively than traditional calcium products and with fewer applications and less input.

 

CaT alleviates the problems encountered by growing crops under environmental stress (drought, heat, cold) and physiological diseases in the ongoing development of the fruit that are often due to calcium deficiencies. This technology enables calcium uptake and retention in the tissues of the plant that would not naturally absorb calcium under normal growing conditions.

 

About Balance

Balance is a product derived from Plant Impact's Speedo technology. Speedo technology has the ability to increase the efficacy of nutrient products. It accelerates reproductive growth leading to faster and better colour, flowering, sugar production and maturity. Earlier yielding crops give the option for additional harvest and or prolonged harvests of extra crops. Speedo technology can be incorporated into other Plant Impact products such as the PiNT technology range as well as into other manufacturers fertilisers under license.

About Cocoa Stress Tolerance ("CST")

CST is a product based principally on Plant Impact's Alethea stress relief technology in combination with PiNT technology. It enables cocoa plants to withstand disease attack by increasing nutrient levels and plant health. There are no cures for diseases such as Frosty Pod and Black Pod so cocoa growers are dependent upon fungicides to reduce yield loss. CST therefore presents growers with the opportunity to reduce fungicide use while adding to the health of the plant nutritionally.

In a 3 year trial on the Costa Rican cocoa crop CST was found to increase cocoa yield by 67% by simply improving disease resistance. In addition calcium levels were also increased by 25% which has a beneficial effect on the flavour of cocoa products such as chocolate.

 

 

For further information please visit www.plantimpact.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKKPDNOBKDQBK
Date   Source Headline
14th Dec 20172:48 pmRNSForm 8.3 - Plant Impact PLC
14th Dec 20172:17 pmRNSForm 8.3 - Plant Impact plc
14th Dec 201712:00 pmRNSForm 8.5 (EPT/RI) Plant Impact Plc
13th Dec 20177:00 amRNSUpdate, Strategic Options and Formal Sale Process
24th Oct 20177:00 amRNSPosting of Annual Report and Notice of AGM
17th Oct 20175:27 pmRNSNotification of Major Holdings
9th Oct 20177:00 amRNSPreliminary Results
27th Sep 20177:00 amRNSNotice of Preliminary Results
20th Sep 20172:40 pmRNSNotification of Major Holdings
15th Aug 20177:00 amRNSR&D Platform and Pipeline Presentation
2nd Aug 20178:46 amRNSTR-1: Notification of Major Holdings
1st Aug 20174:46 pmRNSTR-1: Notification of major holdings
1st Aug 201710:42 amRNSTOTAL VOTING RIGHTS
31st Jul 20173:48 pmRNSNOTIFICATION OF MAJOR HOLDINGS
28th Jul 20173:59 pmRNSDirector/PDMR Shareholding
28th Jul 20173:48 pmRNSNotification of Major Interest in Shares
28th Jul 20173:43 pmRNSNotification of Major Interest in Shares
26th Jul 20173:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
26th Jul 20177:00 amRNSProposed Placing
17th Jul 20177:00 amRNSFull Year Trading Update & Potential Capital Raise
19th Jun 20177:00 amRNSThird Quarter Trading Update
3rd May 20177:00 amRNSNew collaboration with Ghent University
6th Mar 20177:00 amRNSHalf year results
22nd Feb 20175:00 pmRNSUSA launch of Fortalis®
8th Feb 20177:00 amRNSNew Quality Standard
12th Jan 20177:30 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Jan 20177:00 amRNSCORRECTION OF BLOCK LISTING SIX MONTHLY RETURN
9th Dec 20162:17 pmRNSRESULTS OF ANNUAL GENERAL MEETING
9th Dec 20167:00 amRNSAGM Trading Update
2nd Dec 20167:00 amRNSTotal Voting Rights
10th Nov 20167:00 amRNSPosting of Annual Report and Notice of AGM
31st Oct 20167:00 amRNSPreliminary Results
19th Aug 20167:00 amRNSAdoption of FRS 101
3rd Aug 20165:03 pmRNSTotal Voting Rights
6th Jul 20167:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jul 20167:00 amRNSNew Product Intro & Launch of Southern Cone Ops
14th Jun 20167:00 amRNSTrading update
19th May 20167:00 amRNSOption Grant to Recently Appointed CFO
10th May 20167:00 amRNSAppointment of Chief Financial Officer
20th Apr 20167:00 amRNSScientific Advisory Network
6th Apr 20163:55 pmRNSDirector's Dealing
4th Apr 20168:26 amRNSTotal Voting Rights
21st Mar 20167:00 amRNSHalf yearly results
16th Mar 20167:00 amRNSCollaboration on mitigating heat stress in wheat
7th Mar 20167:00 amRNSNotification of Half Year Results
2nd Mar 20163:48 pmRNSTotal Voting Rights
24th Feb 20167:00 amRNSNotification of Major Interest in Shares
19th Feb 20165:19 pmRNSBlock Listing Six Monthly Return
18th Feb 20167:00 amRNSNorth America Operations: Key Senior Appointment
15th Feb 20162:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.